Diabetic Medicine

Assessing vascular risk in people with Type 1 diabetes: implications for the effectiveness of statin therapy
pp. 575-578(4)
Author: McKnight, J. A.

Quality assurance for diabetic retinal screening—can we afford it?
pp. 579-581(3)
Authors: Leese, G. P.; Ellis, J. D.

Hypothesis: the `metabolic memory', the new challenge of diabetes
pp. 582-586(5)
Authors: Ihnat, M. A.; Thorpe, J. E.; Ceriello, A.

Misleading meta-analysis: a need to look beyond the headlines
pp. 587-591(5)
Authors: Chaturvedi, N.; Bilous, R.; Hardy, R.; Remuzzi, G.; Ruggenenti, P.; Viberti, G. C.

The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity
pp. 592-599(8)
Authors: Cunha, M. R.; da Silva, M. E. R.; Machado, H. A.; Fukui, R. T.; Correa, M. R. S.; Santos, R. F.; Wajchenberg, B. L.; Rondon, M. U. P. B.; Negrão, C. E.; Ursich, M. J. M.

Low-dose acarbose does not delay digestion of starch but reduces its bioavailability
pp. 600-606(7)
Authors: Wachters-Hagedoorn, R. E.; Priebe, M. G.; Heimweg, J. A. J.; Heiner, A. M.; Elzinga, H.; Stellaard, F.; Vonk, R. J.

Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes
pp. 607-617(11)
Authors: Barnard, K. D.; Lloyd, C. E.; Skinner, T. C.

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes
pp. 618-625(8)
Authors: Home, P. D.; Bailey, C. J.; Donaldson, J.; Chen, H.; Stewart, M. W.

Rosiglitazone RECORD study: glucose control outcomes at 18 months
pp. 626-634(9)
Authors: Home, P. D.; Jones, N. P.; Pocock, S. J.; Beck-Nielsen, H.; Gomis, R.; Hanefeld, M.; Komajda, M.; Curtis, P.

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy
pp. 635-642(8)
Authors: Pieber, T. R.; Treichel, H-C.; Hompesch, B.; Philotheou, A.; Mordhorst, L.; Gall, M-A.; Robertson, L. I.

A national survey of in-patient diabetes services in the United Kingdom
pp. 643-649(7)
Authors: Sampson, M. J.; Brennan, C.; Dhatariya, K.; Jones, C.; Walden, E.

Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes
pp. 650-655(6)
Authors: Wanic, K.; Malecki, M. T.; Klupa, T.; Warram, J. H.; Sieradzki, J.; Krolewski, A. S.

Subclinical right ventricular dysfunction in diabetes mellitus—an ultrasonic strain/strain rate study
pp. 656-663(8)
Authors: Kosmala, W.; Przewlocka-Kosmala, M.; Mazurek, W.

Perinatal factors associated with subsequent diabetes mellitus in the child: record linkage study
pp. 664-670(7)
Authors: Ievins, R.; Roberts, S. E.; Goldacre, M. J.

Breastfeeding habits in families with Type 1 diabetes
pp. 671-676(6)
Authors: Hummel, S.; Winkler, C.; Schoen, S.; Knopff, A.; Marienfeld, S.; Bonifacio, E.; Ziegler, A. G.

The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia
pp. 677-683(7)
Authors: Krass, I.; Armour, C. L.; Mitchell, B.; Brillant, M.; Dienaar, R.; Hughes, J.; Lau, P.; Peterson, G.; Stewart, K.; Taylor, S.; Wilkinson, J.

Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects
pp. 684-687(4)
Authors: Jauch-Chara, K.; Hallschmid, M.; Schmid, S. M.; Oltmanns, K. M.; Peters, A.; Born, J.; Schultes, B.

Issues regarding quality assurance in the English National Screening Programme for Sight-threatening Diabetic Retinopathy: response to paper by C. Arun et al., `Establishing ongoing quality assurance in a retinal screening programme'
pp. 688-690(3)
Author: Garvican, L.

Authors' response
pp. 690-691(2)
Authors: Taylor, R.; Arun, C. S.

Diary dates
pp. 692-692(1)